GSK has become the first ... RSV in individuals 60 years of age and older, shortly after it was recommended for approval in the EU. The regulator is due to make a decision on Pfizer’s rival ...

The vaccine in play — called Abrysvo — was registered for use in pregnancy by the regulator that approves medicines ... born during or entering their first RSV season and vulnerable children ...

Pfizer's jab, meanwhile, is the only one of the three labelled for use as a maternal vaccine to prevent RSV in newborns and infants, although that is a much smaller market. The EU follows the US ...

There isn't a vaccine for kids yet but high-risk infants often get monthly doses of a protective drug during RSV season,and European regulators recently approved the first one-dose option.

Research suggests the vaccine may pass maternal RSV antibodies onto the fetus to protect newborns from the virus for the first six months of life ... U.S. Food and Drug Administration. FDA approves ...

and against which vaccines currently approved at EU wide-level show little protection," the Amsterdam-based agency said. The BTV-3 strain of the virus was first detected in the Netherlands in ...

EU Approves Synopsys' $35 Billion Ansys Deal Under Conditions (Reuters) -The European Commission on Friday said it had approved the takeover by chip design software maker Synopsys of software ...

The European Commission said it has approved, under the EU merger regulation ... software,” said the European Commission. Published first on TheFly – the ultimate source for real-time ...